BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38054895)

  • 1. The current state of apolipoprotein E in dyslipidemia.
    Rasmussen KL; Frikke-Schmidt R
    Curr Opin Lipidol; 2024 Apr; 35(2):78-84. PubMed ID: 38054895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of Alzheimer Disease-Protective APOE Variants With Age-Related Macular Degeneration.
    Rasmussen KL; Tybjærg-Hansen A; Nordestgaard BG; Frikke-Schmidt R
    JAMA Ophthalmol; 2023 Jan; 141(1):13-21. PubMed ID: 36394841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
    Agarwal R; Tripathi CB
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
    Farrer LA; Cupples LA; Haines JL; Hyman B; Kukull WA; Mayeux R; Myers RH; Pericak-Vance MA; Risch N; van Duijn CM
    JAMA; 1997 Oct 22-29; 278(16):1349-56. PubMed ID: 9343467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration.
    Baird PN; Guida E; Chu DT; Vu HT; Guymer RH
    Invest Ophthalmol Vis Sci; 2004 May; 45(5):1311-5. PubMed ID: 15111582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.
    Chen Q; Wang T; Kang D; Chen L
    Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Uncommon, Noncoding Variants in the APOE Region With Risk of Alzheimer Disease in Adults of European Ancestry.
    Blue EE; Cheng A; Chen S; Yu CE;
    JAMA Netw Open; 2020 Oct; 3(10):e2017666. PubMed ID: 33090224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study.
    Wong TY; Shankar A; Klein R; Bray MS; Couper DJ; Klein BE; Sharrett AR; Folsom AR
    Ophthalmology; 2006 Feb; 113(2):255-9. PubMed ID: 16406547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association of apolipoprotein E with age-related macular degeneration.
    Klaver CC; Kliffen M; van Duijn CM; Hofman A; Cruts M; Grobbee DE; van Broeckhoven C; de Jong PT
    Am J Hum Genet; 1998 Jul; 63(1):200-6. PubMed ID: 9634502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration.
    Souied EH; Benlian P; Amouyel P; Feingold J; Lagarde JP; Munnich A; Kaplan J; Coscas G; Soubrane G
    Am J Ophthalmol; 1998 Mar; 125(3):353-9. PubMed ID: 9512153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.
    Kim HC; Kim DK; Choi IJ; Kang KH; Yi SD; Park J; Park YN
    Psychiatry Clin Neurosci; 2001 Apr; 55(2):115-20. PubMed ID: 11285089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease.
    Le Guen Y; Belloy ME; Grenier-Boley B; de Rojas I; Castillo-Morales A; Jansen I; Nicolas A; Bellenguez C; Dalmasso C; Küçükali F; Eger SJ; Rasmussen KL; Thomassen JQ; Deleuze JF; He Z; Napolioni V; Amouyel P; Jessen F; Kehoe PG; van Duijn C; Tsolaki M; Sánchez-Juan P; Sleegers K; Ingelsson M; Rossi G; Hiltunen M; Sims R; van der Flier WM; Ramirez A; Andreassen OA; Frikke-Schmidt R; Williams J; Ruiz A; Lambert JC; Greicius MD; ; Arosio B; Benussi L; Boland A; Borroni B; Caffarra P; Daian D; Daniele A; Debette S; Dufouil C; Düzel E; Galimberti D; Giedraitis V; Grimmer T; Graff C; Grünblatt E; Hanon O; Hausner L; Heilmann-Heimbach S; Holstege H; Hort J; Jürgen D; Kuulasmaa T; van der Lugt A; Masullo C; Mecocci P; Mehrabian S; de Mendonça A; Moebus S; Nacmias B; Nicolas G; Olaso R; Papenberg G; Parnetti L; Pasquier F; Peters O; Pijnenburg YAL; Popp J; Rainero I; Ramakers I; Riedel-Heller S; Scarmeas N; Scheltens P; Scherbaum N; Schneider A; Seripa D; Soininen H; Solfrizzi V; Spalletta G; Squassina A; van Swieten J; Tegos TJ; Tremolizzo L; Verhey F; Vyhnalek M; Wiltfang J; Boada M; García-González P; Puerta R; Real LM; Álvarez V; Bullido MJ; Clarimon J; García-Alberca JM; Mir P; Moreno F; Pastor P; Piñol-Ripoll G; Molina-Porcel L; Pérez-Tur J; Rodríguez-Rodríguez E; Royo JL; Sánchez-Valle R; Dichgans M; Rujescu D
    JAMA Neurol; 2022 Jul; 79(7):652-663. PubMed ID: 35639372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Age-related macular degeneration: its association with the epsilon4 allele of the apolipoprotein E gene].
    Asensio-Sánchez VM; Rodríguez-Martín T; Gala-Molina I; Rodríguez-Fernández I
    Arch Soc Esp Oftalmol; 2006 Jan; 81(1):9-12. PubMed ID: 16450255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
    Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
    Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders.
    Ferreira CN; Carvalho MG; Fernandes AP; Lima LM; Loures-Valle AA; Dantas J; Janka Z; Palotás A; Sousa MO
    Neurochem Int; 2010 Jan; 56(1):177-82. PubMed ID: 19819279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of APOE in atypical parkinsonism syndromes.
    Sabir MS; Blauwendraat C; Ahmed S; Serrano GE; Beach TG; Perkins M; Rice AC; Masliah E; Morris CM; Pihlstrom L; Pantelyat A; Resnick SM; Cookson MR; Hernandez DG; Albert M; Dawson TM; Rosenthal LS; Houlden H; Pletnikova O; Troncoso J; Scholz SW
    Neurobiol Dis; 2019 Jul; 127():142-146. PubMed ID: 30798004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial Effect of Societal Factors on APOE-ε2 and ε4 Carriers' Brain Health: A Systematic Review.
    Aravena JM; Lee J; Schwartz AE; Nyhan K; Wang SY; Levy BR
    J Gerontol A Biol Sci Med Sci; 2024 Feb; 79(2):. PubMed ID: 37792627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
    Insel PS; Hansson O; Mattsson-Carlgren N
    JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.